
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
- Japan (Japanese)
-
Change country/language
Old Browser
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Pharmingen™ Purified Mouse Anti-MLC2a
クローン S58-205 (RUO)

Immunohistochemical staining of MLC2a in human left atrium and left ventricle Following antigen retrieval with BD Retrievagen A buffer (Cat. No. 550524), the formalin-fixed paraffin-embedded sections were stained with either Purified Mouse IgG1, κ Isotype Control (Cat. No. 550878; top left) or Purified Mouse Anti-MLC2a (top right) on left atrium. Additionally, Purified Mouse Anti-MLC2a (bottom left) and Purified Mouse Anti-MLC2v (Cat. No. 565497, bottom right) were used to stain left ventricle. A three-step staining procedure that employs Biotin Goat Anti-Mouse Ig (Cat. No. 550337), Streptavidin HRP (Cat. No.550946), and the DAB Substrate Kit (Cat. No. 550880) was used to develop the primary staining reagents. The tissues were counterstained with Hematoxylin. Original magnification: 40X (MLC2a) and 20X (MLC2v).

Flow cytometric analysis of MLC2a and MLC2v expression in MLC2a-transfected 293F cells. Untransfected (dashed line histogram) and human MLC2a-transfected (solid line histogram) 293F cells were fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050). The cells were then washed and stained with Purified Mouse Anti-Human MLC2a (Cat. No. 565496, left panel) and Purified Mouse Anti-Human MLC2v (Cat. No. 565497, middle panel) followed by PE Goat Anti-Mouse Ig (Cat. No. 550589). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Western blot analysis of MLC2a expression (right panel). Lysate from MLC2a-transfected 293F cells was prepared for electrophoresis (SDS-PAGE) in a 2D Tris-Glycine polyacrylamide gel. The proteins were transferred to PVDF membranes and then probed with 0.063 (lane 1), 0.032 (lane 2), and 0.016 (lane 3) µg/mL of Purified Mouse Anti-MLC2a. Specific staining was detected with HRP Goat Anti-Mouse Ig (Cat No. 554002).





Immunohistochemical staining of MLC2a in human left atrium and left ventricle Following antigen retrieval with BD Retrievagen A buffer (Cat. No. 550524), the formalin-fixed paraffin-embedded sections were stained with either Purified Mouse IgG1, κ Isotype Control (Cat. No. 550878; top left) or Purified Mouse Anti-MLC2a (top right) on left atrium. Additionally, Purified Mouse Anti-MLC2a (bottom left) and Purified Mouse Anti-MLC2v (Cat. No. 565497, bottom right) were used to stain left ventricle. A three-step staining procedure that employs Biotin Goat Anti-Mouse Ig (Cat. No. 550337), Streptavidin HRP (Cat. No.550946), and the DAB Substrate Kit (Cat. No. 550880) was used to develop the primary staining reagents. The tissues were counterstained with Hematoxylin. Original magnification: 40X (MLC2a) and 20X (MLC2v).
Flow cytometric analysis of MLC2a and MLC2v expression in MLC2a-transfected 293F cells. Untransfected (dashed line histogram) and human MLC2a-transfected (solid line histogram) 293F cells were fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050). The cells were then washed and stained with Purified Mouse Anti-Human MLC2a (Cat. No. 565496, left panel) and Purified Mouse Anti-Human MLC2v (Cat. No. 565497, middle panel) followed by PE Goat Anti-Mouse Ig (Cat. No. 550589). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Western blot analysis of MLC2a expression (right panel). Lysate from MLC2a-transfected 293F cells was prepared for electrophoresis (SDS-PAGE) in a 2D Tris-Glycine polyacrylamide gel. The proteins were transferred to PVDF membranes and then probed with 0.063 (lane 1), 0.032 (lane 2), and 0.016 (lane 3) µg/mL of Purified Mouse Anti-MLC2a. Specific staining was detected with HRP Goat Anti-Mouse Ig (Cat No. 554002).

Immunohistochemical staining of MLC2a in human left atrium and left ventricle Following antigen retrieval with BD Retrievagen A buffer (Cat. No. 550524), the formalin-fixed paraffin-embedded sections were stained with either Purified Mouse IgG1, κ Isotype Control (Cat. No. 550878; top left) or Purified Mouse Anti-MLC2a (top right) on left atrium. Additionally, Purified Mouse Anti-MLC2a (bottom left) and Purified Mouse Anti-MLC2v (Cat. No. 565497, bottom right) were used to stain left ventricle. A three-step staining procedure that employs Biotin Goat Anti-Mouse Ig (Cat. No. 550337), Streptavidin HRP (Cat. No.550946), and the DAB Substrate Kit (Cat. No. 550880) was used to develop the primary staining reagents. The tissues were counterstained with Hematoxylin. Original magnification: 40X (MLC2a) and 20X (MLC2v).



Flow cytometric analysis of MLC2a and MLC2v expression in MLC2a-transfected 293F cells. Untransfected (dashed line histogram) and human MLC2a-transfected (solid line histogram) 293F cells were fixed with BD Cytofix™ Fixation Buffer (Cat. No. 554655) and permeabilized with BD Phosflow™ Perm Buffer III (Cat. No. 558050). The cells were then washed and stained with Purified Mouse Anti-Human MLC2a (Cat. No. 565496, left panel) and Purified Mouse Anti-Human MLC2v (Cat. No. 565497, middle panel) followed by PE Goat Anti-Mouse Ig (Cat. No. 550589). The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells. Flow cytometric analysis was performed using a BD FACSCanto™ II Flow Cytometer System.
Western blot analysis of MLC2a expression (right panel). Lysate from MLC2a-transfected 293F cells was prepared for electrophoresis (SDS-PAGE) in a 2D Tris-Glycine polyacrylamide gel. The proteins were transferred to PVDF membranes and then probed with 0.063 (lane 1), 0.032 (lane 2), and 0.016 (lane 3) µg/mL of Purified Mouse Anti-MLC2a. Specific staining was detected with HRP Goat Anti-Mouse Ig (Cat No. 554002).


BD Pharmingen™ Purified Mouse Anti-MLC2a

BD Pharmingen™ Purified Mouse Anti-MLC2a

BD Pharmingen™ Purified Mouse Anti-MLC2a

BD Pharmingen™ Purified Mouse Anti-MLC2a

Regulatory Statusの凡例
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation and Storage
Product Notices
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- An isotype control should be used at the same concentration as the antibody of interest.
- Sodium azide is a reversible inhibitor of oxidative metabolism; therefore, antibody preparations containing this preservative agent must not be used in cell cultures nor injected into animals. Sodium azide may be removed by washing stained cells or plate-bound antibody or dialyzing soluble antibody in sodium azide-free buffer. Since endotoxin may also affect the results of functional studies, we recommend the NA/LE (No Azide/Low Endotoxin) antibody format, if available, for in vitro and in vivo use.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
関連製品






Myosin is composed of 2 heavy chains, 2 regulatory light chains, and 2 alkali light chains. The S58-205 monoclonal antibody specifically binds to human Myosin regulatory light chain 2, atrial isoform (MLC2a) that is selectively expressed in the cardiac atrium, while the MLC2v isoform is selectively expressed in the cardiac ventrical. The differential expression of the two MLC2 isoforms is first detected early in cardiogenesis, prior to the formation of distinct atrial and ventrical chambers. During the induction of cardiovascular lineage cells from a human embryonic stem cell line, the appearance of contracting cardiomyocytes is coincident with the up-regulation of the expression of several genes, including the genes encoding MLC2a and MLC2v. Cross-reactivity of the S58-205 monoclonal antibody to mouse MLC2a is predicted due to the ~96% conservation of the human and mouse protein sequences.
Development References (5)
-
Dubois NC, Craft AM, Sharma P, et al. SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol. 2011; 29:1011-1018. (Biology). View Reference
-
Franco D, Lamers WH, Moorman AF. Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model. Cardiovasc Res. 1998; 38(1):25-53. (Biology). View Reference
-
Hailstones D, Barton P, Chan-Thomas P, et al. Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development. J Biol Chem. 1992; 267(32):23295-23300. (Biology). View Reference
-
Kubalak SW, Miller-Hance WC, O'Brien TX, Dyson E, Chien KR. Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem. 1994; 269(24):16961-16970. (Biology). View Reference
-
Laflamme MA, Murry CE. Heart regeneration. Nature. 2011; 473(7347):326-335. (Biology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.